These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7099109)

  • 1. Micro-K potassium supplement.
    Med Lett Drugs Ther; 1982 Aug; 24(615):71-2. PubMed ID: 7099109
    [No Abstract]   [Full Text] [Related]  

  • 2. Upper gastrointestinal lesions after potassium chloride supplements: a controlled clinical trial.
    McMahon FG; Ryan JR; Akdamar K; Ertan A
    Lancet; 1982 Nov; 2(8307):1059-61. PubMed ID: 6127542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic comparison of solid and liquid potassium chloride supplements.
    Patterson DJ; Weinstein GS; Jeffries GH
    Lancet; 1983 Nov; 2(8358):1077-8. PubMed ID: 6138615
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of potassium chloride supplements on upper gastrointestinal mucosa.
    McMahon FG; Ryan JR; Akdamar K; Ertan A
    Clin Pharmacol Ther; 1984 Jun; 35(6):852-5. PubMed ID: 6734038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral potassium chloride on upper gastrointestinal mucosa in healthy subjects: healing of lesions despite continuing treatment.
    Moore JG; Alsop WR; Freston JW; Tolman KG
    Gastrointest Endosc; 1986 Jun; 32(3):210-2. PubMed ID: 3522347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforation of small bowel due to slow release potassium chloride (slow-K).
    Farquharson-Roberts MA; Giddings AE; Nunn AJ
    Br Med J; 1975 Jul; 3(5977):206. PubMed ID: 1148734
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of five potassium chloride preparations on the upper gastrointestinal mucosa in healthy subjects receiving glycopyrrolate.
    Alsop WR; Moore JG; Rollins DE; Tolman KG
    J Clin Pharmacol; 1984; 24(5-6):235-9. PubMed ID: 6747020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study on the effects of a combined frusemide and controlled release potassium tablet (Diumide-K Continus tablets) on gastrointestinal mucosa.
    McLoughlin JC
    Br J Clin Pract; 1984 Mar; 38(3):99-101. PubMed ID: 6712879
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology update: slow-release potassium chloride supplements.
    Romankiewicz N
    J Pract Nurs; 1983; 33(7):7-8. PubMed ID: 6555240
    [No Abstract]   [Full Text] [Related]  

  • 10. [Digestive hemorrhage caused by jejunal ulcer ascribed to ingesting potassium chloride tablets].
    Soprani A; Claret Y; Louvel A
    Nouv Presse Med; 1976 Nov; 5(39):2634-5. PubMed ID: 995601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lesions of the small intestine caused by oral administration of potassium].
    Sacks S; Tapia A; Varela N; Rodriguez L; Volochinsky M
    Rev Med Chil; 1970 Jul; 98(7):453-6. PubMed ID: 5501553
    [No Abstract]   [Full Text] [Related]  

  • 12. Endoscopic evaluation of slow-release potassium chloride preparations.
    Kendall C; Krantz KD; Berger A; Sharp T
    Clin Pharmacol Ther; 1985 Jul; 38(1):28-30. PubMed ID: 3891194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium chloride tablets and small bowel stenoses and perforations: two studies in the French Pharmacovigilance system.
    Tréchot P; Moore N; Bresler L; Castot A; Gay G; Netter P; Royer R
    Am J Gastroenterol; 1994 Aug; 89(8):1268. PubMed ID: 8053453
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects on upper gastrointestinal mucosa of three delivery systems of potassium as supplement to frusemide administration.
    McLoughlin JC
    J R Soc Med; 1985 Jun; 78(6):459-62. PubMed ID: 3999081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of stenotic obstruction of the jejunum secondary to slow-release potassium.
    Barloon TJ; Moore SA; Mitros FA
    Am J Gastroenterol; 1986 Mar; 81(3):192-4. PubMed ID: 3953535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potassium chloride preparations and fecal blood loss. A parallel study with a 10 percent solution and a non-enteric-coated waxy-matrix tablet.
    Rider JA; Manner RJ; Swader JI
    JAMA; 1975 Feb; 231(8):836-7. PubMed ID: 1172753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klotrix and other slow-release potassium tablets.
    Med Lett Drugs Ther; 1981 Jan; 23(1):3-4. PubMed ID: 7453668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ulceration and stricture of the esophagus due to oral potassium chloride (slow release tablet) therapy.
    Lambert JR; Newman A
    Am J Gastroenterol; 1980 Jun; 73(6):508-11. PubMed ID: 7424872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release tablets for potassium chloride administration. A pharmacological study.
    Bervenmark H; Eriksson G; Ljungberg S; Paalzow L
    Acta Pharm Suec; 1966 Feb; 3(1):45-58. PubMed ID: 5909431
    [No Abstract]   [Full Text] [Related]  

  • 20. Hazards of Slow K. Small bowel perforation following slow release potassium chloride therapy.
    Siderys H; Linden P
    Indiana Med; 1986 Apr; 79(4):340. PubMed ID: 3711645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.